Glenorchy Capital’s Frontline FRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.54M Buy
187,906
+1,041
+0.6% +$38.3K 0.24% 6
2026
Q1
$6.51M Buy
186,865
+7,918
+4% +$242K 0.38% 6
2025
Q4
$3.9M Sell
178,947
-4,669
-3% -$109K 0.24% 19
2025
Q3
$4.18M Sell
183,616
-7,864
-4% -$159K 0.62% 11
2025
Q2
$3.14M Sell
191,480
-932
-0.5% -$15.8K 0.47% 17
2025
Q1
$2.86M Buy
192,412
+10,087
+6% +$167K 1.76% 17
2024
Q4
$2.59M Buy
182,325
+8,025
+5% +$150K 1.51% 18
2024
Q3
$3.98M Sell
174,300
-1,598
-0.9% -$37.6K 1.25% 9
2024
Q2
$4.53M Buy
175,898
+10,682
+6% +$272K 1.41% 9
2024
Q1
$3.86M Buy
165,216
+6,959
+4% +$157K 1.36% 8
2023
Q4
$3.17M Buy
+158,257
New +$3.27M 1.23% 9

Other funds holding FRO

Glenorchy Capital's FRO Position: Q2 2026 in Review

Glenorchy Capital increased its Frontline (FRO) stake by 0.56% in Q2 2026, buying an estimated $38.3K and bringing the position to 187,906 shares worth $6.54M. The position accounts for 0.24% of the portfolio, ranked #6.

Glenorchy Capital first reported a position in FRO in Q4 2023 and has held it in 11 quarters since. 53 funds tracked by Wall St. Rank hold FRO as of Q2 2026.

  • Glenorchy Capital held 187,906 shares of Frontline worth $6.54M as of Q2 2026.
  • Glenorchy Capital bought 1,041 Frontline shares in Q2 2026, an estimated $38.3K.
  • Frontline made up 0.24% of Glenorchy Capital's portfolio in Q2 2026, its #6 holding.
  • Glenorchy Capital first reported a position in Frontline in Q4 2023 and has held it in 11 quarters since.
  • 53 funds tracked by Wall St. Rank held Frontline as of Q2 2026.

Based on Glenorchy Capital's 13F filing for Q2 2026, filed 29 Jul 2026.